- Home
- IMG vs HOTH Comparison
IMG vs HOTH Comparison
Compare IMG & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMG
- HOTH
- Stock Information
- Founded
- IMG 2011
- HOTH 2017
- Country
- IMG United States
- HOTH United States
- Employees
- IMG N/A
- HOTH N/A
- Industry
- IMG
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- IMG
- HOTH Health Care
- Exchange
- IMG NYSE
- HOTH Nasdaq
- Market Cap
- IMG 7.2M
- HOTH 8.3M
- IPO Year
- IMG 2020
- HOTH 2019
- Fundamental
- Price
- IMG $0.66
- HOTH $0.86
- Analyst Decision
- IMG
- HOTH Strong Buy
- Analyst Count
- IMG 0
- HOTH 3
- Target Price
- IMG N/A
- HOTH $4.00
- AVG Volume (30 Days)
- IMG 639.9K
- HOTH 626.3K
- Earning Date
- IMG 05-27-2025
- HOTH 05-13-2025
- Dividend Yield
- IMG N/A
- HOTH N/A
- EPS Growth
- IMG N/A
- HOTH N/A
- EPS
- IMG N/A
- HOTH N/A
- Revenue
- IMG $3,785,663.00
- HOTH N/A
- Revenue This Year
- IMG $99.05
- HOTH N/A
- Revenue Next Year
- IMG $130.30
- HOTH N/A
- P/E Ratio
- IMG N/A
- HOTH N/A
- Revenue Growth
- IMG 109.62
- HOTH N/A
- 52 Week Low
- IMG $0.25
- HOTH $0.58
- 52 Week High
- IMG $8.00
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- IMG N/A
- HOTH 46.70
- Support Level
- IMG N/A
- HOTH $0.74
- Resistance Level
- IMG N/A
- HOTH $0.84
- Average True Range (ATR)
- IMG 0.00
- HOTH 0.08
- MACD
- IMG 0.00
- HOTH 0.01
- Stochastic Oscillator
- IMG 0.00
- HOTH 83.14
About IMG CIMG INC
CIMG Inc is a coffee and technologies company. The company is a co-packer of single-serve pour-over coffee, coffee brew bags and Dripkits. The company's brand portfolio includes Coffee Blenders, Twin Peaks, Active Cup, Relax Cup, Think Cup, Nude Cup, Pine Ranch Coffee, and Dripkit. Its geographical segments are North America, which accounts for the majority of revenue; and South Korea.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.